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Introduction
A growing body of evidence reveals the complexity of function
of the transcriptional factor CTCF (Klenova et al., 2002;
Ohlsson et al., 2001). CTCF is involved in the transcriptional
regulation of genes implicated in a variety of functions, such
as MYC (Filippova et al., 1996; Klenova et al., 1993), the
chicken lysozyme (Burcin et al., 1997), -amyloid precursor
protein (APP) genes (Vostrov and Quitschke, 1997) and others
(Dunn and Davie, 2003; Ohlsson et al., 2001). CTCF is the
only protein identified so far that mediates enhancer-blocking
activity of vertebrate insulators (Bell et al., 1999). Remarkably,
this enhancer-blocking activity is conserved from Drosophila
to man (Moon et al., 2005). Other functions of CTCF include
the control of imprinted genes (Lewis and Murrell, 2004) and
X-chromosome inactivation (Lee, 2003).
CTCF contains a DNA-binding domain composed of 11
zinc-fingers. The DNA target sequences recognized by CTCF
are fairly long (about 50 bp) and strikingly diverse; no single
consensus sequence can be ascribed to all CTCF binding sites.
CTCF employs different combinations of individual zinc
fingers for its binding within promoters, silencers and
insulators (reviewed by Dunn and Davie, 2003; Klenova et al.,
2002; Ohlsson et al., 2001). Another complexity to understand
CTCF functions is the fact that CTCF protein undergoes post-
translational modifications. It can be phosphorylated by the
protein kinase CK2 (El-Kady and Klenova, 2005; Klenova et
al., 2001), as well as poly(ADP-ribosyl)ated, and this latter
modification regulates its activity as a chromatin insulator
(Klenova and Ohlsson, 2005; Yu et al., 2004).
CTCF is a candidate tumour suppressor gene because of the
loss of heterozygosity involving the CTCF locus at the
chromosome band 16q22 in different malignancies, the finding
of tumour-specific CTCF zinc-finger mutations in various
cancers (Klenova et al., 2002; Ohlsson et al., 2001) and growth-
Multiple functions have been reported for the transcription
factor and candidate tumour suppressor, CTCF. Among
others, they include regulation of cell growth,
differentiation and apoptosis, enhancer-blocking activity
and control of imprinted genes. CTCF is usually localized
in the nucleus and its subcellular distribution during the
cell cycle is dynamic; CTCF was found associated with
mitotic chromosomes and the midbody, suggesting
different roles for CTCF at different stages of the cell cycle.
Here we report the nucleolar localization of CTCF in
several experimental model systems. Translocation of
CTCF from nucleoplasm to the nucleolus was observed
after differentiation of K562 myeloid cells and induction of
apoptosis in MCF7 breast cancer cells. CTCF was also
found in the nucleoli in terminally differentiated rat
trigeminal ganglion neurons. Thus our data show that
nucleolar localization of CTCF is associated with growth
arrest. Interestingly, the 180 kDa poly(ADP-ribosyl)ated
isoform of CTCF was predominantly found in the nucleoli
fractions. By transfecting different CTCF deletion
constructs into cell lines of different origin we demonstrate
that the central zinc-finger domain of CTCF is the region
responsible for nucleolar targeting. Analysis of
subnucleolar localization of CTCF revealed that it is
distributed homogeneously in both dense fibrillar and
granular components of the nucleolus, but is not associated
with fibrillar centres. RNA polymerase I transcription and
protein synthesis were required to sustain nucleolar
localization of CTCF. Notably, the labelling of active
transcription sites by in situ run-on assays demonstrated
that CTCF inhibits nucleolar transcription through a
poly(ADP-ribosyl)ation-dependent mechanism.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/119/9/1746/DC1
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1747CTCF inhibits nucleolar transcription
suppressive features of CTCF (Qi et al., 2003; Rasko et al.,
2001). However, elevated levels of CTCF in breast cancer cells
and tumours have been found to be associated with resistance
to apoptosis (Docquier et al., 2005).
In the majority of cells, CTCF is localized in the nucleus,
independently of its phosphorylation state (Klenova et al.,
2001; Klenova et al., 1993). The CTCF subcellular distribution
during the cell cycle is dynamic and it has been found
associated with mitotic chromosomes (Burke et al., 2005),
mitotic centrosomes as well as the midbody of the cytokinesis
(Zhang et al., 2004a), suggesting different roles for CTCF at
different stages of the cell cycle. However, these studies did
not focus on the nucleolus as a possible subnuclear target for
CTCF. The nucleolus is the subnuclear compartment where
ribosomal RNAs are synthesized, processed and assembled
with ribosomal proteins (Andersen et al., 2002; Grébane-
Younès et al., 2005; Lam et al., 2005; Raska et al., 2004). Apart
from ribosome biogenesis, it is known that the nucleolus has
additional functions such as cell cycle regulation, storage of
nuclear factors, regulation of tumour suppressor and oncogene
activities, and processing of spliceosomal small nuclear U6
RNA, telomerase RNA and signal recognition particle RNA
(Arabi et al., 2005; Carmo-Fonseca et al., 2000; Grandori et
al., 2005; Grébane-Younès et al., 2005; Hernandez-Verdun and
Roussel, 2003; Lam et al., 2005; Olson et al., 2002).
The diversity of the nucleolus function is mirrored by its
ultrastructural complexity. The three basic components of the
nucleolus defined by electron microscopy are: (1) the fibrillar
centre, in which the transcriptional machinery of RNA pol I
concentrates, (2) the surrounding dense fibrillar component
into which nascent rRNA extends and rRNA processing begins,
and (3) the granular component, which contains partially
processed rRNA and where the final stages of ribosome
assembly occur (reviewed by Huang, 2002; Leung and
Lamond, 2003; Raska et al., 2004). Interestingly, CTCF has
been shown to co-purify with the protein of the granular
component B23 (nucleophosmin), and both proteins are
present at the insulator sites in vivo (Yusufzai et al., 2004).
However, it is unknown whether CTCF can be localized in the
nucleolus and if so, whether the subnucleolar localization of
CTCF is regulated and the dynamics of CTCF in the nucleolus
have a functional relevance. In the present study we show that
in response to different stimuli CTCF localizes to the nucleolus
in several human cell lines in culture, and also in rat mature
trigeminal ganglion neurons in vivo. We have identified the
CTCF domain responsible for such localization and found that
the CTCF nucleolar distribution depends on rDNA
transcription and protein synthesis. Finally, we demonstrated
that CTCF inhibits nucleolar transcription and this function is
regulated by poly(ADP-ribosyl)ation.
Results
CTCF is targeted to the nucleolus upon different stimuli
We first explored CTCF localization upon induced
differentiation by taking advantage of the ability of K562
leukaemia cells to undergo pluripotent myeloid differentiation
(Munoz-Alonso et al., 2005). In these experiments, K562 were
differentiated into an erythroid lineage with 1--D-
arabinofuranosylcytosine (Ara-C) or into a megakaryocytic
lineage with staurosporine (STA), and undifferentiated K562
were used as control. Cell differentiation was assessed using
previously established morphological and cytochemical
criteria (Torrano et al., 2005). We then analyzed the distribution
of endogenous CTCF during differentiation of K562 by
immunofluorescence using the anti-CTCF antibody. A low
magnification image (Fig. 1Aa) shows that CTCF is diffusely
distributed throughout the nucleoplasm in undifferentiated
K562 cells. However, CTCF appears in nucleoli following cell
differentiation. Both erythroid (Ara-C-treated) and
megakaryocytic (STA-treated) differentiated cells exhibited an
intense nucleolar CTCF immunostaining (Fig. 1Ae,i). The
nucleolar localization of the CTCF was confirmed in double
immunostaining experiments with antibodies against the
protein B23, a marker of the granular component of the
nucleolus. Thus, in undifferentiated K562 cells, CTCF was
distributed throughout the nucleoplasm, but not concentrated
in nucleoli, which appeared intensely labelled with the anti-
B23 antibody (Fig. 1Ab-d). Erythroid and megakaryocytic
differentiation of K562 cells led to the accumulation of CTCF
in the nucleoli, as illustrated by co-localization of CTCF and
B23 proteins (Fig. 1Af-h,j-l).
The nucleolar localization of CTCF was confirmed by
western analysis of nucleolar extracts from K562 cells. Fig. 1B
shows isolated nucleoli examined with phase-contrast
microscopy and immunostained for the nucleolar protein UBF,
confirming the purity of the nucleolar fraction. As expected,
CTCF was found in the nuclear fraction and whole cell
extracts, but not in the cytoplasmic fraction obtained from
untreated K562 cells (Fig. 1C). CTCF was detected in
nucleolar fractions from both untreated and Ara-C-treated
K562 cells (Fig. 1C), although it was more abundant in nucleoli
from the latter, thus confirming the results obtained by
immunofluorescent staining (Fig. 1A). Interestingly, in
addition to the prevalent CTCF band of 130 kDa, an extra band
of approximately 180 kDa was also detected in the fraction
enriched in nucleoli. This band is likely to correspond to the
previously described poly(ADP-ribosyl)ated form of CTCF
(CTCF-180) (Klenova and Ohlsson, 2005; Yu et al., 2004).
To extend our observations to another model system, we
treated MCF7 breast cancer cells with sodium butyrate (NaBu),
which is a known inhibitor of HDAC activity and inducer of
G2/M growth arrest (Joseph et al., 2005) (D.F., unpublished
data), and apoptosis in MCF7 cells (Chopin et al., 2002;
Chopin et al., 2004). In untreated MCF7 cells CTCF was
diffusely distributed in the nucleoplasm, but strongly
accumulated in nucleoli after NaBu treatment (Fig. 2A).
Nucleolar localization of CTCF in MCF7 cells treated with
NaBu was further confirmed by western analysis of nucleolar
fractions of MCF7 cells (Fig. 2B). Notably, the 180 kDa
poly(ADP-ribosyl)ated form of CTCF, described earlier (Yu et
al., 2004), was the predominant form found in nucleoli of
MCF7 cells, whereas the 130 kDa form of CTCF was more
abundant in the nucleoplasm (Fig. 2B).
Having established the nucleolar localization of CTCF in
human haematopoietic and breast cancer cell lines, we aimed
to further confirm this distribution in cells that model more
closely the in vivo situation. For this study, we selected primary
sensory neurons of rat trigeminal ganglia, which are post-
mitotic differentiated cells with prominent nucleoli (Pena et al.,
2001). Squash preparations of trigeminal ganglion neurons
immunostained with the anti-CTCF and anti-B23 antibodies
revealed co-localization of CTCF and B23 in the nucleolus in
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these cells (Fig. 3A). To investigate the ultrastructural
distribution of CTCF in the nucleolar compartments we
performed immunogold electron microscopy with the rabbit
polyclonal anti-CTCF antibody. As shown in Fig. 3B, gold
particles, indicating CTCF immunoreactivity, decorated the
reticulated strands of dense fibrillar and granular components
of the neuronal nucleolus (Pena et al., 2001), with a preferential
localization on the dense fibrillar component.
CTCF is targeted to the nucleolus by signals within its
zinc-finger domain
To investigate which region of the CTCF protein was
responsible for its nucleolar targeting, we cloned CTCF cDNA
fragments in frame with the C terminus of GFP. The GFP-
CTCF full-length construct was previously shown to have
similar functional characteristics as the wild-type CTCF
protein (Burke et al., 2005). In this study we further confirmed
Journal of Cell Science 119 (9)
this by demonstrating that the full-length fusion protein (GFP-
CTCF) was able to effectively inhibit cell proliferation and
cloning efficiency in K562 cells (Fig. S1 in supplementary
material) similarly to the CTCF protein (Rasko et al., 2001;
Torrano et al., 2005).
K562 cells were then transfected with the different deletion
variants and examined by confocal microscopy 24 hours post-
transfection. In order to avoid possible artefacts due to high
levels of CTCF overexpression, only cells with moderate to
low levels of GFP expression were chosen. Fig. 4A illustrates
the expression pattern of different CTCF variants tagged with
GFP. The full-length GFP-CTCF showed a nuclear
distribution, with higher expression level in the nucleolus (Fig.
4Aa). The N-terminal portion of CTCF failed to localize in the
nucleolus (Fig. 4Ab), the C-terminal portion showed a diffuse
nucleoplasmic distribution of the fusion protein, including the
nucleolar compartment (Fig. 4Ad), whereas the central domain
Fig. 1. Nucleolar localization of endogenous
CTCF in human myeloid cells induced to
differentiate. (A) Indirect
immunofluorescence showing CTCF
nucleolar localization during induced
differentiation of K562 cells. (a-d) Control
undifferentiated K562 cells; (e-h) K562 cells
treated with 1 M 1--D-
arabinofuranosylcytosine (Ara-C) for 3 days
to induce erythroid differentiation;
(i-l) K562 cells treated with 100 nM
staurosporine (STA) for 3 days to induce
megakaryocytic differentiation. After
induction of differentiation, cells were
immunostained with the anti-CTCF
monoclonal antibody. The images at low
magnification show accumulation of CTCF
in nucleoli after induction with Ara-C or
STA (a,e,i). The detailed images show co-
localization of CTCF (b,f,j; green channel)
and B23 (c,g,k; red channel); d,h,l are the
merged images of b and c, f and g and j and
k, respectively. Bars, 40 m in the low
magnification images and 10 m in the high
magnification images. (B) Differential
interference contrast (DIC) images showing
the morphology of the nucleus (Nu) and
isolated nucleoli (NO) from K562 cells (left
panel). The purity of the nucleolar fraction
was assessed by immunostaining with the
anti-UBF antibody (right panel).
(C) Western analysis of nucleolar fractions
isolated from undifferentiated K562 cells
and K562 cells induced into erythroid
differentiation. Cell fractions were obtained,
resolved on the SDS-PAGE, blotted and
probed. Western analysis of nucleolar
fractions isolated from undifferentiated
K562 cells (Cont) and cells treated with 1
M Ara-C for 5 days was performed with
the anti-CTCF antibody (upper panel) and
the anti-UBF antibody (lower panel). The
developed films were scanned and
quantified. In the NO fractions, the ratio of
the intensity of the CTCF bands over the intensity of the corresponding UBF bands revealed a 2.4-fold increase of CTCF expression in the Ara-
C fraction with respect to control. Cyto, cytoplasmic fraction; Nu, nuclear fraction; NO, nucleolar fraction; Total, whole cell extract.
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containing the 11 zinc fingers (ZF) accumulated in the
nucleolus (Fig. 4Ac). Deletion of the N terminus resulted in
strong accumulation of the fusion protein in the nucleolus (Fig.
4Ae), and deletion of the C terminus led to a weak nucleolar
expression of the fusion protein (Fig. 4Af). In cells transfected
with the empty vector, control GFP signal was distributed
throughout the cytoplasm and nucleoplasm, but the nucleoli
were excluded (data not shown).
We next asked whether nucleolar localization of CTCF, as
observed in K562 cells, also occurred in other cell lines. For
this purposed we used the UR61 neuron-like cells, derived
from the rat pheochromocytoma PC12 cell line (Guerrero et
al., 1988). Differentiated UR61 cells have a sympathetic
neuron-like phenotype with inhibited proliferation and
prominent nucleoli (Navascues et al., 2004) making them a
suitable model for the detailed analysis of
CTCF localization. In these experiments,
UR61 cells were transfected with the
indicated GFP-CTCF constructs; after 24
hours, cells were fixed, permeabilized and
counterstained with propidium iodide (PI) to
detect nucleic acids (Fig. 4B). Owing to the
dispersed chromatin configuration of the
UR61 cells, the nucleolus appears intensely
stained with the PI and stands out on the pale
nucleoplasm (Fig. 4Be-h). In UR61 cells
distribution of the different deletion variants
of GFP-CTCF was identical to those observed
Fig. 2. Nucleolar localization of endogenous CTCF
in human breast cancer cells treated with sodium
butyrate. (A) Indirect immunofluorescent staining
showing CTCF nucleolar localization following
treatment of MCF7 cells with sodium butyrate
(NaBu). After induction with 5 mM NaBu for 8
hours, MCF7 cells were immunostained with the
anti-CTCF rabbit polyclonal antibody (a,d) or
stained with DAPI (b,e); (c,f) merged images of
CTCF and DAPI staining. (a-c) Untreated MCF7
cells (control); (d-f) MCF7 cells treated with NaBu.
Bar, 10 m. (B) Nucleolar fractionation and western
analysis of MCF7 cells treated with NaBu. MCF7
cells were treated with 5 mM sodium butyrate for 8
hours, nucleolar fractions were isolated and western
analysis with the rabbit polyclonal anti-CTCF
antibody was performed. Total, whole cell extract;
Np, nucleoplasmic fraction; NO, nucleolar fraction;
Cyto, cytoplasmic fraction.
Fig. 3. Nucleolar localization of endogenous
CTCF in rat neurons in vivo. (A) Confocal laser
microscopy following double immunofluorescent
staining with anti-CTCF rabbit polyclonal
antibody (left panel) and anti-B23 antibody (right
panel) in differentiated neurons from rat
trigeminal ganglia. Bar, 10 m.
(B) Immunoelectron localization of CTCF in the
nucleolus of trigeminal ganglion neurons. Note
the typical reticulated configuration of the
nucleolus with its granular component (GC),
dense fibrillar component (DFC) and fibrillar
centres (FC). Gold particles indicating CTCF
immunoreactivity preferentially decorated the
dense fibrillar component of the nucleolus of rat
neurons. Bar, 200 nm.
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in K562 cells, with clear nucleolar
localization of both the full-length GFP-
CTCF and GFP-CTCF-ZF domain fusion
proteins (Fig. 4Ba,c), diffuse nucleolar
staining of the GFP-CTCF-C-terminal
domain (Fig. 4Bd), and absence of
nucleolar localization when the GFP-
CTCF-N-terminal domain was expressed
(Fig. 4Bb).
Analysis of subnuclear localization of
different CTCF domains fused with GFP
was also performed in HeLa cells; the
results were identical to those obtained in
K562 and UR61 cell lines (Fig. S2 in
supplementary material). The data on the
nucleolar targeting of GFP-CTCF
constructs expressed in the three different
cell lines studied are summarized in Fig.
4C. Taken together, these experiments
demonstrate that the region responsible for
nucleolar targeting of CTCF is localized
within the central zinc-finger domain.
Subnucleolar localization of the GFP-
CTCF full-length in UR61 cells
To define the possible nucleolar
subdomains targeted by CTCF, UR61 cells
were transfected with the full-length GFP-
CTCF construct (Fig. 5A). GFP detection
was either combined with PI staining for
nucleic acids or with immunostaining for
(1) UBF, a transcription factor for rDNA
that is preferentially located in fibrillar
centres, (2) fibrillarin, a marker of the
dense fibrillar component, and (3) B23, a
marker of the granular component.
Analysis of UR61 cells expressing the
GFP-CTCF showed a homogeneous
distribution of the CTCF fusion protein
throughout the nucleolus, which was
counterstained with PI (Fig. 5Aa-c). It is
noteworthy that nucleolar CTCF signal did
not overlap with the small nucleolar dots,
fibrillar centres, characteristic for UBF
immunostaining (Fig. 5Ad-f). However, a
significant co-localization of CTCF with
both fibrillarin (Fig. 5Ag-i) and B23 (Fig.
5Aj-l) was observed in the nucleolus.
These findings indicate that full-length
CTCF is not selectively associated with the
fibrillar centres, but rather distributed more
homogeneously in both the dense fibrillar
and granular components of the nucleolus
in UR61 cells.
Nucleolar localization of the full-length
CTCF protein requires RNA pol I
transcription
To determine a possible role for active
rDNA transcription in the nucleolar
distribution of CTCF, we added
Journal of Cell Science 119 (9)
Fig. 4. The zinc-finger region of CTCF targets it to the nucleolus. (A) The distribution
of the various GFP-CTCF fusion proteins, as described in C, in K562 cells. K562 cells
were transfected with the indicated GFP-CTCF truncated variants, cells were fixed 24
hours post-transfection and green fluorescence was analyzed by confocal microscopy.
Bar, 5 m. (B) The distribution of GFP-CTCF fusion proteins in UR61 cells. UR61 cells
were transfected with the indicated GFP-CTCF truncated variants (as in C), cells were
fixed 24 hours post-transfection and stained with propidium iodide. (a-d) green
fluorescence from GFP-CTCF fusion proteins; (e-h) propidium iodide staining labelling
nucleoli. Bar, 5 m. (C) Schematic representation of the full-length and truncated
versions of CTCF fused to the C terminus of GFP. Numbers denote amino acid
positions. The summary of the nucleolar localization for the different GFP-CTCF fusion
proteins in K562, UR61 and HeLa cells is shown. Fusion proteins were present (+) or
not (–) in the nucleolus as indicated; (++), strong nucleolar accumulation; (±), weak
signal; ND, not determined.
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1751CTCF inhibits nucleolar transcription
actinomycin D (Act D) to the culture
medium of UR61 transfected cells at
concentration sufficient to selectively
inhibit RNA pol I transcription
(Christensen et al., 2004). Treatment
with Act D induced the segregation of
the nucleolar components, as observed
after PI staining (Fig. 5Bb), in
agreement with previous reports
(Puvion-Dutilleul et al., 1992). It is
noteworthy that most of the cells treated
with Act D exhibited a marked
reduction of GFP-CTCF labelling in the
nucleolus compared with untreated
cells (Fig. 5Ba,d,g,j), indicating that
targeting of CTCF to the nucleolus is
dependent on nucleolar transcription.
We then analyzed the localization of
CTCF in the nucleoli of UR61 cells
treated with Act D by using
immunofluorescent staining for the
nucleolar markers UBF (Fig. 5Bd-f),
fibrillarin (Fig. 5Bg-i) and B23 (Fig.
5Bj-l). Following treatment with Act D,
fibrillar centres immunostained with the
anti-UBF antibody were reorganized to
form one or two larger dots free of
CTCF (Fig. 5Bd-f). Furthermore, the
nucleolar remnant of GFP-CTCF
showed a diffuse distribution and was
not specifically segregated with the
fibrillarin-positive (Fig. 5Bg-i) or B23-
positive (Fig. 5Bj-l) nucleolar domains.
In order to investigate whether the
Act D-induced inhibition of the
nucleolar targeting of CTCF is
dependent on the full-length form of
this protein, we next transfected UR61
cells with the construct harbouring the
central zinc-finger domain of CTCF
tagged with GFP (GFP-ZF), and
exposed these cells to low doses of the
RNA pol I inhibitor Act D (Fig. 6). As
described above, GFP-ZF signal was
strongly concentrated in nucleoli
counterstained with PI in untreated cells
(Fig. 4Bc,g; Fig. 6Aa-c). The nucleolar
distribution pattern of this fusion
protein in nucleolar domains
immunostained for UBF, fibrillarin and
B23 was similar to that observed in
UR61 cells transfected with the GFP-
CTCF construct (Fig. 6Ad-l). As
expected, Act D treatment for 1 hour
induced nucleolar segregation in most
nucleoli. In these cases, the fusion
protein was segregated with the rRNA-
enriched domains of the nucleolus
stained with PI (Fig. 6Ba-c).
Interestingly, the GFP-ZF fusion
protein remained in the nucleoli after
Fig. 5. Nucleolar localization of CTCF is dependent on the transcription from rDNA.
UR61 cells were transfected with the full-length CTCF fused with the GFP (GFP-CTCF)
and either left untreated (A) or treated 24 hours post-transfection with 0.05 g/ml
actinomycin D (ActD) for 1 hour to specifically inhibit RNA pol I (B). Cells were fixed,
immunostained for UBF, fibrillarin or B23 as indicated. Nucleic acids were visualized with
propidium iodide (PI). The localization of the GFP-CTCF fusion protein (a,d,g,j; green
channel), the markers for the different nucleolar compartments (b,e,h,k; red channel) and
the merged images (c,f,i,l) are shown. Confocal images show that GFP-CTCF is released
from the nucleolus upon inhibition of transcription by RNA pol I. Bar, 20 m in a; 10 m
in b-l.
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inhibition of RNA pol I (Fig. 6Ba,d,g,j).
Moreover, this fusion protein was not
concentrated in the larger fibrillar centres
immunolabelled with the anti-UBF
antibody (Fig. 6Bd-f) or in the
segregated masses of dense fibrillar
component stained with the anti-
fibrillarin antibody (Fig. 6Bg-i).
However, the nucleolar distribution
pattern of GFP-ZF was similar to that of
the protein B23 (Fig. 6Bj-l).
Taken together, these results indicate
that the full-length form of CTCF can
accumulate in both the dense fibrillar
component, where rRNA transcription
and pre-rRNA processing take place, and
the granular component, the site of
ribosome assembly. This nucleolar
localization is dynamic, depends on the
transcription of rDNA and necessitates
the full length CTCF protein.
Nucleolar localization of the full-
length CTCF requires de novo
protein synthesis
We next asked whether inhibition of
protein synthesis could have an effect on
the localization of CTCF. The blockage
of protein synthesis can be achieved with
cycloheximide (Chx); it leads to a rapid
depletion of short half-life transcription
factors of the RNA polymerase I complex
and inhibition of rDNA transcription and
pre-rRNA processing (Gokal et al., 1986;
Stoykova et al., 1985). In these
experiments, UR61 cells were transfected
with GFP-CTCF or GFP-ZF constructs
and, 24 hours post-transfection, treated
with Chx for 3 hours (Fig. 7b,d). Whereas
untreated UR61 cells exhibited typical
nucleolar accumulation of GFP-CTCF
fusion protein (Fig. 7a,e), Chx treatment
prevented the nucleolar targeting of GFP-
CTCF, which was completely excluded
from the nucleolus counterstained with PI
(Fig. 7b,f). This effect was not so
apparent in cells transfected with the
zinc-finger domain, since a moderate
GFP-ZF signal remained in the nucleolus
after exposure to Chx (Fig. 7d,h), in
comparison with the higher nucleolar
signal detected in untreated transfected
cells (Fig. 7c,g). In summary, the
Cyclohexamide-induced inhibition of de
novo protein synthesis interferes with the
targeting of CTCF to the nucleolus.
Nucleolar transcription is inhibited by
full length CTCF
To gain an insight into the functional
significance of the nucleolar CTCF, we
Journal of Cell Science 119 (9)
Fig. 6. Nucleolar localization of the zinc-finger region of CTCF is independent of the
transcription from rDNA. UR61 cells were transfected with the construct harbouring the
central zinc-finger domain of CTCF fused with the GFP (GFP-ZF) and either left untreated
(A) or treated 24 hours post-transfection with 0.05 g/ml actinomycin D (ActD) (B) for 1
hour to specifically inhibit RNA pol I. Cells were fixed and immunostained for UBF,
fibrillarin or B23 as indicated. Nucleic acids were visualized with propidium iodide (PI).
The localization of the GFP-ZF fusion protein (a,d,g,j; green channel), the markers for the
different nucleolar compartments (b,e,h,k; red channel) and the merged images (c,f,i,l) are
shown. Confocal images show that GFP-ZF remains in the nucleolus following the
inhibition of RNA pol I transcription. Bars, 10 m.
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investigated the possible involvement of CTCF in the
regulation of nucleolar transcription. We therefore performed
an in situ run-on assay based on the incorporation of 5-
fluorouridine (5-FU) into nascent RNA, which labels active
transcription sites (Boisvert et al., 2000). UR61 cells were
transfected with full-length GFP-CTCF (Fig. 8a,d), the GFP-
ZF domain (Fig. 8g) or the GFP vector (Fig. 8j). Twenty-four
hours post-transfection, cells were exposed to pulses of 5-FU,
and subsequently immunostained for the detection of the
halogenated nucleotide. In agreement with the high level of
transcription in nucleoli, short pulses of 5-FU for 5 minutes
(Fig. 8b) and 10 minutes (Fig. 8e,h,k) resulted in the
incorporation of 5-FU predominantly into nascent pre-rRNA
at the nucleolar transcription sites, and foci of 5-FU signal
were clearly observed within the nucleolus (arrow in Fig. 8b).
However, in cells transfected with GFP-CTCF, the
incorporation of 5-FU into nucleoli was undetectable or very
weak (Fig. 8a-c,d-f). By contrast, the nucleolar patterns of 5-
FU incorporation in cells transfected with GFP-ZF or GFP
were similar to that observed in non-transfected cells (Fig. 8g-
i,j-l and Fig. 9, upper panel). We conclude that full-length
CTCF, but not the CTCF-ZF domain, dramatically inhibits
nucleolar transcription.
Inhibition of PAR polymerases impairs the targeting of
CTCF to the nucleolus
Since the poly(ADP-ribosyl)ated form of CTCF (CTCF-180)
was detected in nucleolar fractions of K562 (Fig. 1C) and
MCF7 (Fig. 2B) cells, we investigated the possible
involvement of poly(ADP-ribosyl)ation of this factor in its
nucleolar targeting. We analyzed the effect of the PAR
polymerase inhibitor 3-aminobenzamide (ABA) on the
nucleolar localization of GFP-CTCF and GFP-ZF variants, as
well as on the nucleolar transcription, in UR61 cells.
Following ABA treatment, nucleoli preserved the normal
staining pattern with PI (Fig. 10b) and with the anti-UBF
antibody (Fig. 10e). Interestingly, most of the transfected
cells did not accumulate GFP-CTCF in nucleoli after ABA
treatment (Fig. 10a-i and Fig. 9, lower panel). On the
contrary, ABA did not interfere with the nucleolar
localization of the GFP-ZF variant (Fig. 10j). Furthermore,
following ABA treatment, a similar pattern of 5-FU
incorporation in nucleoli was observed in non-transfected
cells and cells transfected with GFP-CTCF (Fig. 10g-i and
Fig. 9). This indicates that treatment with ABA interferes
with nucleolar localization of CTCF leading to activation of
transcription in the nucleolus. As expected, the patterns of 5-
FU incorporation in cells transfected with the GFP-ZF (Fig.
10j-l) or GFP (data not shown) constructs were similar to that
detected in non-transfected cells. In summary, inhibition of
poly(ADP-ribosyl)ation impairs CTCF nucleolar
translocation, resulting in the restoration of active nucleolar
transcription.
Discussion
CTCF accumulates in nucleoli of mammalian cells upon
different stimuli
In this report we show that CTCF accumulates in the nucleoli
upon induction of differentiation in human myeloid cells and
induction of growth arrest and apoptosis in human breast
carcinoma cells. Furthermore, CTCF has been found in the
nucleoli of differentiated adult rat neurons in vivo. The
common characteristic between these cell models is inhibition
of cell proliferation, which may be linked to the presence of
CTCF in nucleoli. By using K562 cells, we previously
demonstrated that CTCF is differentially regulated during
myeloid differentiation (Delgado et al., 1999) and has a
functional role in the regulation of the erythroid pathway
(Torrano et al., 2005). In this report, we show that
differentiation of K562 cells into erythroid and megakaryocytic
lineages is accompanied by relocation of CTCF to the
nucleolus. Similarly, in MCF7 cells, CTCF shifts from
nucleoplasm to the nucleolus following NaBu treatment. Such
redistribution of CTCF in the nucleus may be important to
trigger and sustain necessary metabolic changes leading to cell
growth arrest and, further, to terminal differentiation and
apoptosis.
CTCF is a predominantly nucleoplasmic protein in the
majority of cells and its translocation to the nucleolus is likely
to be a dynamic process and a consequence of functional
interactions with other macromolecules. This resembles the
situation with MYC, which is usually a nucleoplasmic
Fig. 7. Full-length CTCF, but not
CTCF-ZF localization in the
nucleolus requires protein synthesis.
UR61 cells were transfected with
the GFP-CTCF full length (GFP-
CTCF; a,b,e,f) or with the GFP-
CTCF-zinc-finger (GFP-ZF;
c,d,g,h). 24 hours post-transfection
cells were treated with 20 g/ml
cycloheximide (Chx) for 3 hours to
inhibit protein synthesis. Untreated
cells served as control. Cells were
then fixed and analyzed by confocal
microscopy for green fluorescence
(a-d). Nucleoli were stained with
propidium iodide (e-h). GFP-CTCF
fusion protein, but not GFP-ZF, is
delocalized from the nucleolus upon
protein synthesis inhibition with
cycloheximide. Bar, 5 m.
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transcription factor rarely found in nucleoli in normal cells
(Arabi et al., 2003). Nevertheless, MYC plays an important
role in the regulation of rDNA transcription (Arabi et al., 2005;
Grandori et al., 2005). A number of nuclear factors have been
found to be transiently present in the nucleoli, continuously
exchanging with the nucleoplasm (Dundr and Misteli, 2002).
Such dynamic interactions with the nucleolus often depend on
the metabolic state of the cell (Andersen et al., 2002). These
findings may explain why CTCF has not been identified in the
nucleolar proteome in HeLa cells (Andersen et al., 2005;
Andersen et al., 2002).
The zinc-finger domain targets CTCF to the nucleolus
In this study, by using recombinant proteins of full-length and
truncated versions of CTCF fused to the GFP, we have
demonstrated that the central zinc-finger region of CTCF,
which is responsible for DNA binding in the silencing function
of CTCF, is also responsible for its nucleolar targeting. This
has been demonstrated in three cell lines of different origin
(K562, UR61 and HeLa). In previous studies, CTCF over-
expression was found to be strongly associated with growth
suppression (El-Kady and Klenova, 2005; Qi et al., 2003;
Rasko et al., 2001; Torrano et al., 2005). Here, we found that
Fig. 8. Full-length CTCF, but
not CTCF-ZF, inhibits
nucleolar transcription.
UR61 cells were transfected
with the GFP-CTCF full
length (GFP-CTCF; a-c,d-f),
the GFP-CTCF-zinc-finger
(GFP-ZF; g-i) or the pEGFP
vector (GFP; j-l). 24 hours
post-transfection cells were
pulse-labelled with 5-
fluorouridine (FU) for 5
minutes (b) or 10 minutes
(e,h,k). Cells were then fixed
and the sites of 5-FU
incorporation revealed with
an anti-BrdU antibody and a
Texas Red-conjugated
secondary antibody. The
localization of the GFP-
fusion proteins (a,d,g,j; green
channel), the 5-FU
incorporation (b,e,h,k; red
channel) and the merged
images (c,f,i,l) are shown.
Confocal images show that
GFP-CTCF, but not GFP-ZF
or GFP inhibits 5-FU
incorporation into nascent
RNA. Bar, 10 m.
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transiently over-expressed GFP-CTCF protein was targeted
into nucleoli in the population of proliferating cells. It may be
significant for initiation of the processes required for growth
inhibition caused by ectopic CTCF.
A strong nucleolar accumulation of CTCF was only
observed when the 11 zinc-finger region was expressed, while
the N-terminal or the C-terminal regions were dispensable for
the nucleolar targeting of the CTCF (Fig. 4C). Interestingly,
when the zinc finger domain is divided in two halves
(constructs ZF-1-5 or ZF-6-11) they can still mediate nucleolar
targeting in HeLa cells, thus indicating that there may be two
regions in the DNA-binding zinc-finger domain of CTCF that
are important for such localization (Fig. S2 in supplementary
material). It is noteworthy that this central zinc-finger region
is capable of binding not only DNA targets, but also proteins,
for example the Y-box DNA/RNA-binding factor YB-1 which
may also be involved in the nucleolar targeting of CTCF
(Chernukhin et al., 2000; Klenova et al., 2004; Ohlsson et al.,
2001). Interestingly, the C-terminal zinc fingers (ZF-6-11) are
necessary for targeting of CTCF to mitotic chromosomes
(Burke et al., 2005) thus pointing to the importance of the DNA
binding domain for targeting into different nuclear
compartments.
Inspection of the protein sequence of the CTCF zinc-finger
domain revealed three possible nucleolar localization signals
(NuLS) containing a characteristic arginine hinge flanked by
basic amino acids, proposed to be a consensus for some NuLS
(Henderson et al., 1995) (not shown). Evidence for this short
sequence being a consensus for NuLS are, however, conflicting
(Schmidt-Zachmann and Nigg, 1993) and the exact sequences
responsible for nucleolar targeting of CTCF within the zinc-
finger domain remain to be established. In addition, it is
conceivable that localization of CTCF in nucleoli may not only
be signal mediated, but dependent on RNA-binding, which
would involve other components such as RGG box and GAR
box motifs (Siomi and Dreyfuss, 1997).
CTCF is associated with several components of the
nucleolus
To determine the subnucleolar distribution of CTCF within the
nucleolus we have analysed the co-localization of the CTCF
with UBF, fibrillarin or B23. The rDNA transcription factor
UBF is associated with rDNA loci within the nucleolus, which
can be observed as discrete foci corresponding to fibrillar
centres (Roussel et al., 1993). In contrast, CTCF labelling is
much more homogeneous and does not show the characteristic
foci labelling seen with UBF. CTCF is therefore not selectively
associated with the fibrillar centres, but homogeneously
distributed throughout the dense fibrillar and granular
components of the nucleolus. These results suggest that CTCF
function in the nucleoli may be associated with synthesis and
processing of pre-rRNA (dense fibrillar component) and pre-
ribosomal (granular component) assembly.
Interestingly, B23 and CTCF were found to be present at the
insulator sites in vivo and exogenous insulator sequences
tethered to the nucleolus in a CTCF-dependent manner (Yusufzai
et al., 2004). Our results of double immunofluorescence analysis
for CTCF and B23 are consistent with the co-localization of both
proteins in nucleolar subdomains.
The nucleolar accumulation of CTCF depends on active
RNA pol I transcription and protein synthesis
Our results indicate that CTCF fails to accumulate in the
nucleolus after inhibition of pol I transcription with low doses
of Act D. Treatment with Chx, which leads to a depletion of
short-lived transcription factors required by the pol I
transcription machinery and severe nucleolar dysfunction
(Cavanaugh et al., 2002 and references therein), also prevents
translocation of CTCF to the nucleolus. Collectively, these
findings indicate that targeting of CTCF to the nucleolus
requires ongoing rDNA transcription and protein synthesis.
This suggests a dynamic exchange of CTCF between the
nucleolus and the nucleoplasm rather than the passive storage
of this factor in the nucleolar compartment and also points to
the existence of a protein interaction network important for
CTCF translocation in the nucleolus. Similar networks have
been proposed for other factors that accumulate in the nucleolus
in the same way as CTCF (Desterro et al., 2003; Straight et al.,
1999; Zhang et al., 2004b).
In contrast to the CTCF-full length form, the central zinc-
finger domain accumulates in the nucleolus after treatment
with Act D and Chx. Thus, Act D-induced depletion from the
nucleoli of CTCF depends on the full-length protein, whereas
the nucleolar localization of the DNA binding zinc-finger
domain is not affected by this treatment. We hypothesize that
translocation of the full-length CTCF in the nucleolus or/and
Fig. 9. Quantification of nucleolar localization of the GFP fusion
proteins and FU incorporation in nucleoli, in untreated cells and cells
treated with ABA. UR61 cells, untreated (Control, upper panel) and
treated with 3-aminobenzamide for 8 hours (ABA, lower panel) were
transfected with GFP-CTCF, GFP-ZF and GFP. 24 hours post-
transfection, cells were pulse-labelled with 5-FU for 10 minutes and
cells showing nucleolar localization of the GFP fusion proteins (bars
on the left) and cells showing 5-FU incorporation in nucleoli (bars
on the right) were scored. Data show the percentage of cells (mean ±
s.e.m.) from three experiments.
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
1756
its retention there may be regulated processes that require the
N- and C-terminal domains and depend on the presence of
particular types of RNA and/or proteins. Interestingly, the full-
length CTCF, but not the zinc-finger fusion protein, was
functionally active in inhibiting cell growth in a clonogenic
assay (Fig. S1 in supplementary material), in agreement with
previous reports showing cell growth inhibition by CTCF
(Rasko et al., 2001; Torrano et al., 2005).
CTCF has a functional role inhibiting nucleolar
transcription that depends on active PARP
In this study we demonstrate the involvement of CTCF in the
Journal of Cell Science 119 (9)
inhibition of the nucleolar transcription. To identify the
functional role of CTCF in the nucleolus, we performed run-
on transcription assays, which provide a powerful tool to
investigate the overall activity of gene expression in situ, in
both cell cultures (Boisvert et al., 2000) and animal models
(Casafont et al., 2006). Following short pulses of 5-FU
incorporation, a high concentration of nascent 5-FU-labeled
RNA was found in the nucleolus, consistent with the intense
transcriptional activity of ribosomal genes (Russell and
Zomerdijk, 2005). 5-FU-incorporation clearly delineated the
nucleolar sites of transcription in non-transfected UR61 cells
or cells transfected with the GFP-ZF-fusion protein, whereas a
Fig. 10. Inhibition of PARPs
impairs nucleolar localization
of CTCF-full length, but not
CTCF-ZF. UR61 cells were
treated for 8 hours with 3-
aminobenzamide (ABA) and
then transfected with the
GFP-CTCF full length (GFP-
CTCF; a-c,d-f,g-i), or with
the GFP-CTCF-zinc-finger
domain (GFP-ZF; j-l). 24
hours post-transfection cells
were analyzed by confocal
microscopy for green
fluorescence (a,d,g,j).
Nucleoli were stained with
propidium iodide (PI; b), or
immunostained for UBF (e).
Cells were also pulsed with
5-FU for 10 minutes (h,k);
merged images are also
shown (c,f,i,l).
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weaker or no detectable signal was found in cells transfected
with the full-length GFP-CTCF protein (see Fig. 8). These
findings strongly suggest CTCF involvement in the control of
rDNA transcription. Intriguingly, CTCF binding sites in the
rDNA of Xenopus have been found (West et al., 2002) although
further studies are required to define the precise role of CTCF
in the regulation of rDNA transcription.
The importance of the fine balance between the proliferation
status of the cell and the accumulation of rRNAs, which is
mainly controlled at the level of rDNA transcription, has
already been recognized (Russell and Zomerdijk, 2005). In line
with these findings, our results, showing nucleolar
accumulation of endogenous CTCF in growth-arrested cells,
suggest that nucleolar location of CTCF may be an important
mechanism to simultaneously block cell proliferation and
transcription from rDNA.
Recent studies have shown that poly(ADP-ribosyl)ation of
CTCF regulates its activity as a chromatin insulator (Klenova
and Ohlsson, 2005; Yu et al., 2004). Increasing numbers of
roles of poly(ADP-ribosyl)ation in critical cellular processes
such as DNA damage, chromatin modification, transcription
regulation and many others have been described (Kim et al.,
2005; Rouleau et al., 2004). In the present report, significant
levels of the 180 kDa CTCF isoform, likely to represent
poly(ADP-ribosyl)ated CTCF, were found in the nucleoli in
K562 and MCF7 cell lines. Using a PARP inhibitor (ABA) we
found that inhibition of poly(ADP-ribosyl)ation impaired the
translocation of the full-length CTCF into the nucleolus and
restored nucleolar transcription, thus indicating that inhibition
of nucleolar transcription by CTCF depends on active
poly(ADP-ribosyl)ation. Interestingly, PARP-1 and PARP-2,
have been found to accumulate in nucleoli in a complex with
B23 (Meder et al., 2005). It is conceivable that CTCF may be
a part of the same functional network, as interaction with
PARP-1 and B23 has been documented (Yusufzai et al., 2004).
In summary, we conclude that the nucleolar localization of
CTCF, associated to growth inhibition, cell differentiation or
apoptosis has a functional significance, inhibiting the
transcription of the nucleolus through mechanisms involving
CTCF poly(ADP-ribosyl)ation.
Materials and Methods
Cell culture, induction of differentiation and drugs treatment
The myeloid K562 cells (from the American Type Culture Collection) were grown in
suspension in RPMI 1640 medium (Invitrogen) supplemented with 8% foetal calf
serum (Biochrome). The erythroid and megakaryocytic differentiation was induced
with 1 M 1--D-arabinofuranosylcytosine (Ara-C; Upjohn) and 100 nM
staurosporine (STA) (Roche), respectively, and monitored as previously described
(Munoz-Alonso et al., 2005). Human breast carcinoma MCF7 cells were maintained
in RPMI 1640 supplemented with 10% foetal calf serum. Growth arrest in MCF7 cells
was induced with 5 mM sodium butyrate (NaBu) for 8 hours. Longer exposures to
NaBu leads to apoptotic cell death (Chopin et al., 2002; Chopin et al., 2004; Docquier
et al., 2005). HeLa cells, from human cervical carcinoma, were grown in DMEM
medium supplemented with 10% foetal calf serum. UR61 cells, derived from the rat
pheochromocytoma PC12 cell line (Guerrero et al., 1988), were grown attached to the
plates in RPMI 1640 medium supplemented with 10% foetal calf serum and 500 g/ml
of G418. Where indicated, UR61 cells were incubated with 0.05 g/ml actinomycin
D (Act D) (Sigma) for 1 hour to selectively inhibit RNA pol I transcription (Christensen
et al., 2004), with 20 g/ml of cycloheximide (Chx) for 3 hours to inhibit protein
synthesis (Mattsson et al., 2001) or with 8 mM 3-aminobenzamide (ABA) (Sigma) to
inhibit poly(ADP-ribose) polymerases (Yu et al., 2004).
Transfections and clonogenicity assays
Cells were transfected with full-length and truncated versions of CTCF fused to the
C terminus of EGFP. The construction of the GFP-CTCF plasmids has been
previously described (Burke et al., 2005). For transient transfections, 5106 K562
cells in exponential growth were resuspended in 0.8 ml of RPMI-8% FCS containing
10 g of the different expression constructs and electroporated at 260 V and 1 mFa
with a Bio-Rad electroporator. UR61 cells were transiently transfected with 1 g
of plasmid DNA using FuGene 6 transfection reagent (Roche). Cells were analyzed
24 hours post-transfection.
For clonogenicity assays, K562/S, a derivative of the K562 cell line able to grow
attached to plastic (Delgado et al., 2000), was used. 2106 cells growing in p60
plates were electroporated with 5 g of pEGFP-C2-derived constructs: pEGFP
vector (GFP), full-length CTCF (GFP-CTCF) or CTCF-zinc-finger region (GFP-
ZF). 36 hours post-transfection, G418 (500 g/ml) was added and the colonies were
counted after 12 days of selection.
Isolation of nucleoli and western analysis
Extracts enriched in nucleoli were prepared from K562 cells untreated or treated
for 4 days with 1 M Ara-C, essentially as previously described (Andersen et al.,
2002).
For western analysis, samples were resuspended in Laemmli buffer, separated on
a 8% SDS-PAGE gel, transferred onto a nitrocellulose membrane (Millipore) and
probed. Antibodies used were: anti-CTCF monoclonal antibody (1:500; BD
Biosciences), anti-CTCF polyclonal antibody (1:500; Abcam, Cambridge, UK) and
anti-UBF monoclonal antibody (1:500; Santa Cruz Biotechnology).
Immunocomplexes were detected by a chemiluminescent method (ECL,
Amersham) following the manufacturer’s instructions.
Preparation of trigeminal ganglion neurons
Young adult male Sprague-Dawley rats were used. The animals were housed,
supervised and handled according to the approved national guidelines for animal
care. For immunofluorescence, animals were fixed with 3.7% paraformaldehyde,
trigeminal ganglia were removed and squash preparations of neurons were made as
previously described (Pena et al., 2001).
Immunofluorescence and confocal and immunoelectron
microscopy
The UR61 cells grown on glass coverslips were fixed for 10 minutes in 3.7%
paraformaldehyde in PBS. Cells were permeabilized with 0.5% Triton X-100 for
10 minutes, and successively incubated with primary (overnight incubation at 4°C)
and secondary antibodies. Propidium iodide staining (4 g/ml final concentration)
of fixed and permeabilized cells was performed for 5 minutes. K562 cells were
routinely fixed with methanol for 10 minutes at –20°C and immunostaining was
performed as above. For endogenous nucleolar CTCF detection of K562 or MCF7,
an additional modification involving a step of microwave heating after fixation in
formaldehyde was included (Docquier et al., 2005).
Primary antibodies used were: anti-CTCF mouse monoclonal (1:100; BD
Biosciences), anti-CTCF rabbit polyclonal (1:30; Abcam), anti-UBF (1:200;
Santa Cruz), mouse monoclonal anti-fibrillarin (Reimer et al., 1987), anti-
B23/nucleophosmin (1:50; Santa Cruz). Secondary antibodies (Jackson
Laboratories) were conjugated with Texas red or FITC. For detection of GFP-CTCF
fusion proteins, transfected cells were fixed in 3.7% paraformaldehyde,
permeabilized with 0.5% Triton X-100 for 10 minutes and mounted with anti-fading
mounting medium Vectashield (Vector Laboratories) with or without DAPI to
visualize the nucleus. Cell samples were examined using a Zeiss 63 NA 1.4
PlanApo objective. Images were recorded using a Bio-Rad MRC 1024 confocal
laser microscope equipped with argon (488 nm) and HeNe (543 nm) lasers.
Immunoelectron microscopy of rat trigeminal ganglia neurons was performed as
described previously (Pena et al., 2001). Briefly, animals were fixed with 4%
paraformaldehyde and small segments of trigeminal ganglia were dehydrated and
embedded in Lowicryl K4M (Sigma) at –20°C. Ultra-thin sections were sequentially
incubated with 0.1 M glycine in PBS, the primary anti-CTCF rabbit polyclonal
antibody and the secondary antibody conjugated to 10 nm or 15 nm gold particles
(1:25; Biocell Technology). The sections were stained with uranyl acetate and lead
citrate. As controls, sections were treated as described but the primary antibody was
omitted.
Run-on transcription assay
For immunodetection of nascent RNA, pulses of 5-fluorouridine (5-FU) (Sigma)
were administered essentially as described previously (Boisvert et al., 2000). UR61
cells were transfected with different pEGFP-derived constructs and 24 hours post-
transfection 5-FU was added, to a final concentration of 2 mM in the culture
medium. After 5 or 10 minutes, cells were fixed with 3.7% paraformaldehyde in
HPEM buffer (30 mM Hepes, 65 mM Pipes, 2 mM EGTA, 2 mM MgCl2) containing
0.5% Triton X-100 for 10 minutes. The incorporation of 5-FU into nascent RNA
was detected with an antibody against halogenated UTP (1:50, anti-BrdU clone BU-
33; Sigma) and a Texas Red-conjugated secondary antibody (Jackson Laboratories).
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